Profile data is unavailable for this security.
About the company
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
- Revenue in CAD (TTM)32.84m
- Net income in CAD7.05m
- Incorporated1999
- Employees0.00
- LocationBiosyent Inc2476 Argentia Road, Suite 402MISSISSAUGA L5N 6M1CanadaCAN
- Phone+1 (905) 206-0013
- Fax+1 (905) 206-1413
- Websitehttps://www.biosyent.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals Inc | 39.60m | -41.71m | 115.26m | 176.00 | -- | 5.45 | -- | 2.91 | -2.28 | -2.28 | 2.16 | 1.15 | 0.3954 | 1.00 | 3.41 | 164,437.50 | -40.88 | -34.75 | -59.15 | -46.91 | 58.36 | 55.98 | -103.40 | -153.72 | 3.25 | -76.70 | 0.5458 | -- | -21.41 | -- | 34.27 | -- | 14.65 | -- |
| Oncolys Biopharma Inc | 245.67k | -17.34m | 116.08m | 34.00 | -- | 7.51 | -- | 472.49 | -107.77 | -107.77 | 1.52 | 84.14 | 0.0127 | 0.00 | 0.1476 | 824,647.10 | -89.46 | -45.75 | -101.52 | -51.86 | 100.00 | 60.46 | -7,058.44 | -233.66 | 8.82 | -- | 0.1416 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| Lee's Pharmaceutical Holdings Ltd | 184.57m | 2.93m | 117.66m | 1.06k | 40.20 | 0.3292 | 4.30 | 0.6375 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Biosyent Inc | 32.84m | 7.05m | 117.91m | 0.00 | 17.08 | 3.36 | 15.69 | 3.59 | 0.5856 | 0.5856 | 2.72 | 2.97 | 0.8341 | 1.23 | 10.80 | -- | 17.92 | 14.77 | 20.00 | 16.92 | 80.41 | 79.74 | 21.48 | 19.99 | 6.37 | -- | 0.0329 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Albert David Ltd | 59.34m | 12.35m | 118.10m | 1.50k | 9.56 | 1.88 | 8.77 | 1.99 | 132.16 | 132.16 | 635.15 | 671.05 | 0.7868 | 2.58 | 11.23 | 2,421,254.00 | 16.37 | 10.00 | 20.85 | 13.15 | 65.13 | 59.85 | 20.81 | 11.87 | 3.29 | 124.70 | 0.0086 | 12.89 | 6.12 | 2.72 | 108.49 | 33.59 | 40.87 | 13.90 |
| Sakar Healthcare Ltd | 25.10m | 1.91m | 118.80m | 297.00 | 59.90 | 2.77 | 24.42 | 4.73 | 5.57 | 5.57 | 73.21 | 120.61 | 0.423 | 3.88 | 7.13 | -- | 3.22 | 5.26 | 3.81 | 6.28 | 45.43 | 44.13 | 7.60 | 10.12 | 0.743 | 2.68 | 0.2322 | -- | 14.99 | 17.58 | -8.53 | 11.76 | 19.05 | -- |
| YSP Southeast Asia Holding Bhd | 107.99m | 11.83m | 119.45m | 519.00 | 10.09 | 0.9956 | 7.18 | 1.11 | 0.2844 | 0.2844 | 2.60 | 2.88 | 0.7154 | 1.67 | 4.53 | -- | 7.95 | 5.83 | 9.41 | 6.83 | 43.99 | 42.57 | 11.12 | 8.46 | 3.29 | 89.20 | 0.1088 | 39.47 | 6.21 | 4.22 | 8.27 | 4.22 | 4.29 | 2.71 |
| Vita Life Sciences Limited | 68.30m | 8.36m | 119.46m | 124.00 | 13.85 | 2.99 | 13.53 | 1.75 | 0.166 | 0.166 | 1.36 | 0.7695 | 1.33 | 2.34 | 7.35 | -- | 16.27 | 15.25 | 22.51 | 21.99 | 58.14 | 60.90 | 12.24 | 11.71 | 2.29 | -- | 0.0089 | 39.05 | 10.88 | 12.50 | 28.18 | 30.07 | 12.15 | 19.14 |
| Zhong Yuan Bio-Technology Holdings Ltd | 3.41m | 317.50k | 120.72m | 35.00 | 391.37 | 348.44 | -- | 35.38 | 0.0128 | -0.0176 | 0.1395 | 0.0143 | 0.8583 | -1.61 | 3.25 | 71,253.43 | 6.49 | -- | 19.10 | -- | 106.30 | -- | 7.57 | -- | 0.8309 | 2.53 | 0.8593 | -- | -28.60 | -- | -148.37 | -- | -- | -- |
